Page 120 - AN-3-2
P. 120

Advanced Neurology                                                      POTS and pregnancy: A case series



            regional anesthesia (epidural) and fluids. No complications   that her autonomic dysfunction worsened in the latter
            occurred during delivery, which involved continuous   stages of pregnancy, but postpartum was stable at her pre-
            monitoring of her BP. At 6 weeks postpartum, the patient   pregnancy level.
            reported no complications. Her autonomic dysfunction   At 6 months postpartum, the patient became pregnant
            was stable at her pre-pregnancy level.             with her second child. At the onset of hypertension, her

            2.3. Case 3                                        pyridostigmine dose was reduced to 30  mg, 3  times a
                                                               day. Her BP peaked at SBP = 140. The patient started to
            A 26-year-old primigravida presented to our neurology   experience lower leg swelling, back pain, numbness,
            clinic with a pregnancy complicated by POTS. Her medical   tingling of the hands, nausea, and constipation during her
            history was significant for cerebral palsy, at a moderate   second trimester. At 38 weeks of gestation, the patient had
            level requiring leg braces and crutches for ambulation. She   a spontaneous vaginal delivery, resulting in the birth of a
            was also diagnosed with POTS, 10 years prior with a tilt   healthy female infant weighing 3316 g. After delivery, the
            table test. At initial diagnosis, her POTS was reported as   patient initially experienced hypertension of 136/90, which
            severe, with symptoms altering between syncopal episodes   stabilized 1 month postpartum. She subsequently reported
            with hypotension and emesis occurring with hypertension.   stability of her autonomic dysfunction issues compared to
            Her symptoms stabilized and became more manageable   her prepartum state.
            with the assistance of pyridostigmine (30 – 60 mg, 4 times
            daily). The patient was cleared for pregnancy and did not   2.4. Case 4
            require any fertility treatments.                  A  29-year-old patient  with an  unspecific  mitochondrial
              Throughout the patient’s pregnancy, consistent   disorder and autonomic dysfunction presented to our
            monitoring of BP was performed under the direction   neurology clinic. At initial diagnosis, her POTS was reported
            of our autonomic neurology team. Her pregnancy was   as severe, with symptoms alternating between hypotension
            also closely followed by an MFM specialist. During the   (~70/40) and hypertension (~140/90). Her symptoms
            first trimester, the patient experienced worsening POTS   worsened over 8 years but had become more manageable
            symptoms, including increased nausea, palpitations, and   with the assistance of IV fluids to provide volume support.
            unstable  BP,  which  resulted  in  mobility  difficulties.  The   Due to side effects, she was not able to tolerate treatment
            second trimester was similar to the first, but the patient   with pyridostigmine and fludrocortisone. She did not seek
            reported feeling physically the best during this stage of   prepartum stabilization and presented in her first trimester
            pregnancy. The third trimester consisted of increasing   of pregnancy.
            POTS symptoms, including intolerable headaches and   Throughout the patient’s pregnancy, consistent
            fluctuating BP. Her SBP increased to >140 for more than   monitoring of BP was performed under the direction of
            3  days.  Considering her  persistent hypertension, her   our autonomic neurology team. Her pregnancy was also
            pyridostigmine was decreased from 60 to 30 mg, 3 times   closely followed by an MFM specialist. During pregnancy,
            daily.                                             the patient received up to 1.5 L of fluids daily for volume
              An MFM specialist was aware of labor risks and   stabilization and baseline hypotension (~80 – 90/40 – 60),
            closely monitored her delivery, including providing   which was managed by her primary team. During the
            volume support with intravenous (IV) fluids. At 39 weeks   first trimester, the patient experienced an increase in her
            of gestation, the patient was induced and had a vaginal   baseline pressures to ~100/70. Moving into her second
            delivery with forceps assistance. She delivered a healthy   trimester, her BP stabilized, and the patient reported
            female infant weighing 3033  g. She received regional   feeling physically the best during this stage of pregnancy.
            anesthesia (epidural) at 3  cm dilation, Pitocin at 6  cm   Her symptoms worsened during her third trimester with
            dilation, and experienced a labor duration of 30  h. No   the  development  of  lower  extremity  edema  and  a  BP  of
            complications  occurred  during  delivery,  which  involved   ~130/90. She was suspected by neurology to have pre-
            continuous monitoring of her BP every 20 min due to her   eclampsia due to the relative BP augmentation and the
            issues with hypertension.                          edema she experienced in her third trimester.

              After delivery, the patient experienced reoccurring   At 38  weeks of gestation, the patient had a vacuum-
            headaches, reported to be less severe than during the third   assisted vaginal delivery, resulting in the birth of a female
            trimester of pregnancy, and  swollen  legs.  At  5  months   infant weighing 3232 g. The patient did not receive regional
            postpartum, the patient struggled with hypotension,   anesthesia (epidural) but required bi-level positive airway
            particularly in the morning. Her dose of pyridostigmine   pressure during active delivery due to respiratory failure.
            was increased to 60 mg, 3 times a day. The patient reported   Immediately after delivery, the infant appeared hypertonic,


            Volume 3 Issue 2 (2024)                         3                                doi: 10.36922/an.3164
   115   116   117   118   119   120   121   122   123   124   125